HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, announced that a peer-reviewed article in JACC: Advances demonstrated that a risk prediction algorithm incorporating its credit card-sized HeartBeam ECG device can accurately identify heart attack risk in patients presenting with chest pain.
The proof-of-concept study evaluated 184 patients and found that the algorithm achieved an area under the curve (AUC) of 86.5% using a single HeartBeam ECG reading combined with patient risk factors and symptoms. When a personal, symptom-free baseline ECG was available for comparison, the AUC rose to 92.9%. The company said the results support heart attack detection as a future indication for the HeartBeam System and advance its broader clinical program.
HeartBeam is creating the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility.
The HeartBeam System with 12-Lead ECG synthesis software for arrhythmia assessment received FDA clearance in December 2025. The company holds over 20 issued patents related to technology enablement. For details on the intended use of its technology, refer to the cleared indications for use at https://www.heartbeam.com/indications.
To view the full press release, visit https://ibn.fm/ainxV. The latest news and updates relating to BEAT are available in the company's newsroom at https://ibn.fm/BEAT.
Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially. These forward-looking statements are subject to risks set forth under the heading "Risk Factors" in the company's most recent Annual Report on Form 10-K or any updates in subsequent filings with the SEC. All parties undertake no duty to update this information unless required by law.
